0001181431-12-040421.txt : 20120711
0001181431-12-040421.hdr.sgml : 20120711
20120711170325
ACCESSION NUMBER: 0001181431-12-040421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120709
FILED AS OF DATE: 20120711
DATE AS OF CHANGE: 20120711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FERRARI LOUIS
CENTRAL INDEX KEY: 0001513697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 12958132
MAIL ADDRESS:
STREET 1: 765 WARREN STREET
CITY: WARRREN STREET
STATE: NJ
ZIP: 07090
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd350893.xml
FERRARI FORM 4
X0306
4
2012-07-09
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001513697
FERRARI LOUIS
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER, 14TH FLOOR
EAST BRUNSWICK
NJ
08816
0
1
0
0
President and CEO
Option to Purchase Common Stock, $.01 par value
0.56
2012-07-09
4
A
0
150000
0.56
A
2013-07-09
2022-07-09
Common Stock, $.01 par value per share
150000
150000
D
These options shall vest and become exercisable as to 75,000 shares on each of July 9, 2013 and July 9, 2014, provided the optionee remains employed by the Company on these dates
/s/ Irina Ishak for Louis Ferrari
2012-07-11